loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 207930 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 GLYCOPYRROLATE; INDACATEROL MALEATE (1)

filter

01 NOVARTIS (1)

filter

01 POWDER;INHALATION (1)

filter

01 15.6MCG/INH;27.5MCG/INH (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;INHALATION
15.6MCG/INH;27.5MCG/IN...
UTIBRON
USA
207930
2015-10-29
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 207930

Looking for CTD TGA MCC DOSSIER APPLICATION 207930 1

19

Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is GLYCOPYRROLATE; INDACATEROL MALEATE, with a corresponding application number 207930 and regulatory information .

proudly manufactured in the

approval since 2015-10-29

Novartis Pharmaceuticals Corporation's UTIBRON POWDER;INHALATION, medication with 15.6MCG/INH;27.5MCG/INH of GLYCOPYRROLATE; INDACATEROL MALEATE.

Post Enquiry
POST ENQUIRY